Brief: Cytodyn Announced Updates On 49 COVID-19 Patients Who Have Received Leronlimab Under FDA Program
30/04/2020 12:30
April 30 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN - ANNOUNCED UPDATES ON 49 COVID-19 PATIENTS WHO
HAVE
RECEIVED LERONLIMAB UNDER FDA'S EIND PROGRAM
* CYTODYN - FIVE ADDITIONAL COVID-19 PATIENTS APPROVED TO
GET
LERONLIMAB UNDER EINDS, WHICH INCREASES TOTAL EINDS APPROVED BY
FDA TO 54 PATIENTS
Source text for Eikon: ID:nGNX6Xmd4c
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer